Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Stevens

Showing results (1171-1180 of 1,367) with videos related to

Pageof 137
Sort By:
The American Journal of Pathology|September 12, 2000
The role of cyclooxygenase 2 in ulcerative colitis-associated neoplasiaS N Agoff, T A Brentnall, D A Crispin, et al.
Cell|January 2, 2018
Allosteric Coupling of Drug Binding and Intracellular Signaling in the A<sub>2A</sub> Adenosine ReceptorMatthew T Eddy, Ming-Yue Lee, Zhan-Guo Gao, et al.
Journal of Molecular Biology|June 17, 2008
Structural and biochemical characterization of the therapeutic Anabaena variabilis phenylalanine ammonia lyaseLin Wang, Alejandra Gamez, Holly Archer, et al.
Psychopharmacology|August 17, 2013
fMRI response during figural memory task performance in college drinkersAlecia D Dager, Sharna Jamadar, Michael C Stevens, et al.
Nature Communications|February 9, 2019
Human substance P receptor binding mode of the antagonist drug aprepitant by NMR and crystallographyShuanghong Chen, Mengjie Lu, Dongsheng Liu, et al.
American Journal of Medical Genetics. Part A|September 24, 2025
Clinically Irrelevant Terminal 16q21 Deletion Detected by NIPT Is Attributable to Inherited Fragility at FRA16BServi J C Stevens, Wanwisa van Dijk, Nicole Y Souren, et al.
Plos Pathogens|May 23, 2013
Identification of fibroblast growth factor receptor 3 (FGFR3) as a protein receptor for botulinum neurotoxin serotype A (BoNT/A)Birgitte P S Jacky, Patton E Garay, Jérôme Dupuy, et al.
The Journal of Pediatrics|May 29, 2002
Docosahexaenoic acid and arachidonic acid enhance growth with no adverse effects in preterm infants fed formulaSheila M Innis, David H Adamkin, Robert T Hall, et al.
Human Mutation|April 25, 2018
De novo mutations in the SET nuclear proto-oncogene, encoding a component of the inhibitor of histone acetyltransferases (INHAT) complex in patients with nonsyndromic intellectual disabilityServi J C Stevens, Vyne van der Schoot, Magalie S Leduc, et al.
Journal of the American College of Cardiology|August 14, 2001
Antiarrhythmic drug therapy in the Multicenter UnSustained Tachycardia Trial (MUSTT): drug testing and as-treated analysisD G Wyse, M Talajic, G E Hafley, et al.
Pageof 137

Showing results (1171-1180 of 1,367) with videos related to

Sort By:
Pageof 137
The American Journal of Pathology|September 12, 2000
The role of cyclooxygenase 2 in ulcerative colitis-associated neoplasiaS N Agoff, T A Brentnall, D A Crispin, et al.
Cell|January 2, 2018
Allosteric Coupling of Drug Binding and Intracellular Signaling in the A<sub>2A</sub> Adenosine ReceptorMatthew T Eddy, Ming-Yue Lee, Zhan-Guo Gao, et al.
Journal of Molecular Biology|June 17, 2008
Structural and biochemical characterization of the therapeutic Anabaena variabilis phenylalanine ammonia lyaseLin Wang, Alejandra Gamez, Holly Archer, et al.
Psychopharmacology|August 17, 2013
fMRI response during figural memory task performance in college drinkersAlecia D Dager, Sharna Jamadar, Michael C Stevens, et al.
Nature Communications|February 9, 2019
Human substance P receptor binding mode of the antagonist drug aprepitant by NMR and crystallographyShuanghong Chen, Mengjie Lu, Dongsheng Liu, et al.
American Journal of Medical Genetics. Part A|September 24, 2025
Clinically Irrelevant Terminal 16q21 Deletion Detected by NIPT Is Attributable to Inherited Fragility at FRA16BServi J C Stevens, Wanwisa van Dijk, Nicole Y Souren, et al.
Plos Pathogens|May 23, 2013
Identification of fibroblast growth factor receptor 3 (FGFR3) as a protein receptor for botulinum neurotoxin serotype A (BoNT/A)Birgitte P S Jacky, Patton E Garay, Jérôme Dupuy, et al.
The Journal of Pediatrics|May 29, 2002
Docosahexaenoic acid and arachidonic acid enhance growth with no adverse effects in preterm infants fed formulaSheila M Innis, David H Adamkin, Robert T Hall, et al.
Human Mutation|April 25, 2018
De novo mutations in the SET nuclear proto-oncogene, encoding a component of the inhibitor of histone acetyltransferases (INHAT) complex in patients with nonsyndromic intellectual disabilityServi J C Stevens, Vyne van der Schoot, Magalie S Leduc, et al.
Journal of the American College of Cardiology|August 14, 2001
Antiarrhythmic drug therapy in the Multicenter UnSustained Tachycardia Trial (MUSTT): drug testing and as-treated analysisD G Wyse, M Talajic, G E Hafley, et al.
Pageof 137